FDA Inspection
Aesica Pharmaceutical GmbHAesica Pharmaceutical GmbH – FDA Inspection, Nov 11, 2011
Record Details
This FDA Inspection record concerns Aesica Pharmaceutical GmbH, with an inspection on November 11, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Aesica Pharmaceutical GmbH
- Inspection Date
- November 11, 2011
- Product Type
- Drugs
View Company Profile
ID · 6cc1eb00-373b-489f-8362-2f9f7cf09e41
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 759369
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Aesica Pharmaceutical GmbH
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 12, 2024 | VAI | Drug Quality Assurance | |
| July 1, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 17, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Aesica Pharmaceutical GmbH
- FDA Inspection 1306304 - 2024-09-12
- FDA Inspection 1190265 - 2021-07-01
- FDA Inspection 1032046 - 2017-09-20
- FDA Inspection 866229 - 2014-01-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.